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Fuel-Stimulated Insulin Secretion Depends upon 
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The pancreatic islet β-cell is uniquely specialized to couple its metabolism and rates of insulin secretion with the levels of circu-
lating nutrient fuels, with the mitochondrial playing a central regulatory role in this process. In the β-cell, mitochondrial activa-
tion generates an integrated signal reflecting rates of oxidativephosphorylation, Kreb’s cycle flux, and anaplerosis that ultimately 
determines the rate of insulin exocytosis. Mitochondrial activation can be regulated by proton leak and mediated by UCP2, and 
by alkalinization to utilize the pH gradient to drive substrate and ion transport. Converging lines of evidence support the hy-
pothesis that substrate cycles driven by rates of Kreb’s cycle flux and by anaplerosis play an integral role in coupling responsive 
changes in mitochondrial metabolism with insulin secretion. The components and mechanisms that account for the integrated 
signal of ATP production, substrate cycling, the regulation of cellular redox state, and the production of other secondary signal-
ing intermediates are operative in both rodent and human islet β-cells.
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INTRODUCTION
Mitochondria are key to the unique and specialized ability of 
the pancreatic islet β-cell to couple metabolism and rates of 
insulin secretion with the levels of circulating nutrient fuels. 
Of the signals generated by mitochondria, ATP production is 
recognized as the principle nucleotide messenger for coupling 
mitochondrial metabolism with insulin secretion [1,2]. The 
postprandial increase in plasma glucose levels is matched by 
increased glucose uptake, glycolysis, and mitochondrial me-
tabolism by the β-cell. Higher rates of glycolysis and mitochon-
drial metabolism lead to higher ATP levels triggering insulin 
release through a cascade of events mediated by the initial clo-
sure of the ATP-dependent potassium channels (KATP) and 
subsequent influx of Ca
2+ [1-3]. In addition to ATP, rates of in-
sulin secretion have been shown to be regulated by rates of 
mitochondria anaplerosis and mitochondrial-cytosolic sub-
strate cycling [4-7]. This review will first discuss potential 
mechanisms regulating the activation of the mitochondria, 
followed by a discussion of the hypothesis that mitochondrial 
activation generates an integrated signal reflecting rates of oxi-
dativephosphorylation, Kreb’s cycle flux, anaplerosis, and sub-
strate cycles that ultimately determines the rate of insulin exo-
cytosis. 
Review
http://dx.doi.org/10.4093/dmj.2011.35.5.458
pISSN 2233-6079 · eISSN 2233-6087459
Mitochondria activation of substrate cycles of insulin secretion 
Diabetes Metab J 2011;35:458-465 http://e-dmj.org
UNCOUPLING AS A REGULATOR OF 
MITOCHONDRIAL ACTIVATION: UCP2 
ACTIVATION AND H
+ DEPENDENT 
MITOCHONDRIAL CARRIERS
Increased rates of ATP synthesis is a direct consequence of the 
activation of mithochondrial metabolism. The efficiency of 
ATP synthesis by mitochondrial oxidativephosphorylation is 
determined in part by the proportion of the total proton flux 
channeled through ATP synthase from the mitochondrial in-
termembrane space back into the matrix. Any proton “leak-
age” across the inner mitochondria would therefore reduce the 
efficiency of ATP production. Although, the biological func-
tion and activation of UCP2 remains a matter of active debate, 
both in vivo and in vitro evidence support its functioning as a 
conduit for dissipating the mitochondrial protonmotive [8,9]. 
This has led to the hypothesis, supported by the work of Zhang 
et al. [8], that eliminating UCP2 would enhance both mito-
chondrial activation and fuel-stimulated insulin secretion. Al-
ternatively, a teleological argument can be made that the func-
tional consequences of UCP2 activity is to prevent the damag-
ing effects of excessive reactive oxygen species (ROS) produc-
tion. In support of this concept is the work of Krauss et al. [9] 
showing that while ROS as a class is not an activator of UCP2, 
superoxide is a potent activator. These results corroborate the 
recent report showing that the absence of UCP2 in several 
congenic strains of Ucp(-/-) mice have elevated markers of oxi-
dative stress [10].
  Our recent work exploring the mechanisms underlying im-
paired glucose-stimulated insulin secretion (GSIS) in patients 
with Maturity Onset of Diabetes of the Young-Type 3 (MODY-
3) suggests that UCP2 activation may contribute to β-cell dys-
function [11]. Real-time 
31P-NMR measured rates of ATP syn-
thesis, showed that the mitochondria from β-cell lines ex-
pressing a dominant-negative mutation in the HNF-1α that is 
responsible for MODY-3 (DN-HNF-1α) were more uncoupled 
and less efficient for the synthesis of ATP under conditions of 
nutrient-stimulated insulin secretion [11]. Intriguingly, UCP2 
mRNA expression was no different than the controls suggest-
ing that enhanced activation of UCP2 is responsible for the 
change in uncoupling activity. Our observation is analogous to 
an earlier study examining the normalization of GSIS in phlo-
rizin treated db/db mice, where islet function was enhanced, 
despite the persistence of high UCP2 expression in the islets 
[12]. While, they did not present data on mitochondrial func-
tion, the improved islet function may be explained in part by a 
reduction in the activation of UCP2. 
  Invoking UCP2 activation is only one of several possibilities 
though for diverting the protonmotive force away from ATP 
synthesis. The proton gradient is also used to couple the trans-
port of metabolites and H
+, leaving open the possibility that 
the apparent increase mitochondrial uncoupling is the result 
of increases in transport through SCL25 carriers that co-trans-
port metabolites [13], or to increase flux through the H
+/Ca
2+ 
antiporter [14]. Further studies to identify the mechanism 
regulating mitochondrial uncoupling in β-cells, and its role in 
insulin secretion are needed to address these possibilities. Al-
though, changes in the flux through the H
+ dependent carriers 
may appear to be detrimental to mitochondrial function by 
reducing the efficiency of oxidative phosphorylation, they may 
in fact be necessary for other aspects of mitochondrial activa-
tion. Evidence to support this more holistic view of mitochon-
drial uncoupling is evident in the work of Wiederkehr et al. 
[15] on the role of mitochondrial alkalinization in mitochon-
drial activation. 
MITOCHONDRIAL METABOLISM IS 
ACTIVATED BY MATRIX ALKALINIZATION
A quick review of the basic features of mitochondrial electro-
chemical potential will illustrate the notion that, like calcium, 
the alkalinization of mitochondrial matrix pH can be added as 
an activator of mitochondrial metabolism and hence fuel-stim-
ulated insulin secretion [15]. Oxidation of pyruvate by the re-
actions of the Kreb’s cycle is paired to the transfer of reducing 
equivalents to the electron transport chain localized within 
the inner mitochondrial membrane. A portion of the free en-
ergy lost during the transfer of electrons from each of the com-
plexes of the electron transport chain is used to drive the ejec-
tion of protons from the matrix to the intermembrane space 
and sets up an electrical potential, Δψ, and a proton gradient, 
ΔpH, across the inner mitochondrial membrane. This electro-
chemical potential, ΔµH+, is used to drive the synthesis of ATP 
and the transport of various metabolites. Under normal physi-
ological conditions, the Δψ is the major contributor to the 
overall magnitude of electrochemical potential contributing to 
ATP synthesis [16]. 
  As mentioned above, the proton gradient, ΔpH, is utilized 
by several mitochondrial carrier proteins to transport metabo-
lites across the mitochondria inner membrane [13,17], such 460
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that the proton gradient, per se, may contribute to the ability of 
the pancreatic β-cell to function as a nutrient sensor. Glucose 
stimulation increased the mitochondrial pH by ~0.4 in both 
primary β-cells and stable β-cell lines [15]. Consequently, ATP 
synthesis was dependent on the pH gradient with cellular ATP 
concentrations correlating with the kinetics of matrix alkalini-
zation. The dependence of ATP synthesis upon matrix alkalin-
ization to establish a pH gradient, together with the observa-
tion that alkalinization neither required nor was dependent 
upon Ca
2+, suggest that fuel-stimulated mitochondrial alkalini-
zation is another mechanism for activation of β-cell mitochon-
dria. By regulating the transport of Ca
2+ [14,18], and essential 
substrates such as phosphate, glutamate, and possibly pyruvate 
into the mitochondria [13,16], changes in pH gradient may 
regulate and sustain mitochondrial ATP synthesis and the 
production and transport of second messengers necessary for 
the amplification pathways of insulin secretion [1,4-7,16]. 
While the data clearly show a correlation between ATP synthe-
sis and mitochondrial alkalinization, it is not yet clear which 
mitochondrial carriers, in addition to glutamate carrier 1, the 
phosphate carrier [13], and the recently identified Ca
2+/H
+ an-
tiporter [14], may be affected as ΔpH increases, or how this 
impacts transport activity and the exchange of metabolites be-
tween the mitochondrial matrix and the cytosol. 
ANAPLEROSIS AND MITOCHONDRIAL-
CYTOSOLIC PYRUVATE CYCLING
The last several years have seen renewed interest in the role 
that substrate cycling of anaplerotic products may have for 
regulating insulin secretion. Unlike other metabolically-re-
sponsive cells, such as myocytes and hepatocytes, β-cells can-
not accommodate the postpandrial increase in glucose uptake 
and glycolytic flux by storing the excess glucose as glycogen or 
eliminate it as lactate. Without an increase in energy demand 
that matches the increased glycolytic flux, feedback inhibition 
would limit the requisite metabolic responsiveness of the 
β-cell. Substrate cycling provides a mechanism to allow glyco-
lytic and mitochondrial fluxes to increase in direct proportion 
to circulating concentrations of glucose and other fuel secreta-
gogues. 
  Anaplerosis increases the concentrations of several Kreb’s 
cycle intermediates generating a surplus of mitochondrial ma-
late and citrate that can then be exported to the cytosol (Fig. 
1). The concept that a β-cell pyruvate-malate cycle serves to 
couple metabolism with insulin secretion was advanced to 
provide a rationale for the relatively high activity of both pyru-
vate carboxylase and cytosolic malic enzyme in the β-cell [4-
7,19,20]. Malate that is exported from the mitochondria to the 
cytosol is regenerated to pyruvate by cytosolic malic enzyme 
for cycling back to the mitochondria. As part of this pyruvate 
cycle, mitochondrial NADH reducing equivalents are trans-
ferred to cytosolic NADPH. Several lines of evidence support 
the notion of cytosolic NADPH assuming the role of a second 
messenger to couple increased mitochondrial activity with 
downstream cytosolic events leading to insulin secretion [21-
23]. A more elaborate malate-pyruvate cycle occurs by way of 
citrate efflux via the citrate/isocitrate carrier. Together with cy-
tosolic malic enzyme, ATP citrate lyase, and malate dehydro-
genase, this pathway provide another means of cycling citrate 
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Fig. 1.  Pyruvate (PYR) and Phospho-enol-pyruvate (PEP) 
cycles are hypothesized to play a role in coupling anaplerosis 
through pyruvate carboxylase (PC), and by the rate of the 
Krebs cycle determined by pyruvate dehydrogenase (PDH). 
(A) Pyruvate cycling is dependent upon anaplerosis to carbox-
ylate pyruvate to oxaloacetate (OAA) by PC, and thereby gen-
erate excess malate and citrate. Export of either transfers re-
ducing equivalents from mitochondrial NADH to cytosolic 
NADPH by the action of malic enzyme (ME) [19]. Alterna-
tively, citrate can be converted to isocitrate and shunted back 
toα ketoglutarate (αKG) by the activity of isocitrate dehydro-
genase (ICD) and reduction of NADP+ to NADPH [24,25]. 
(B) PEP cycling is dependent upon the synthesis of GTP by 
the activity of the GTP isoform of succinyl-CoA-synthetase 
(SCS-GTP) [32]. The GTP synthesized by the activity of SCS-
GTP is then used to drive the synthesis of PEP by the activity 
of the mitochondrial isoform of Phospho-enol-pyruvate car-
boxykinase (PEPCK-M) [33]. Mitochondrial PEP is exported 
to the cytosolic PEP pool to enhance glucose-stimulated insu-
lin secretion by an undetermined mechanism.
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to malate and back to pyruvate [24,25]. In addition to the ful-
filling the task of generating the putative second messenger, 
cytosolic NADPH, Farfari et al. [5] suggested that this citrate-
malate-pyruvate cycle serves to regenerate NAD
+ and main-
tain glycolytic flux. Alternatively, cytosolic NADPH can be 
generated by a shunting of citrate to isocitrate and back to 
α-ketoglutarate.
  The relevance of the pyruvate-malate cycle mediated by cy-
tosolic malic enzyme has been challenged by recent results 
that confirmed a role for malic enzyme in INS-1 cells, but not 
rat islets [26]. However, the interpretation of the negative re-
sults when malic enzyme was silenced by adenovirus has to be 
accepted with reservation. The possibility of significant effects 
on GSIS from the control shRNA by itself could lead to misin-
terpretation of the observed changes in GSIS when using the 
shRNA to target malic enzyme. In addition, no supporting 
functional data was presented to support changes in enzyme 
activity or pyruvate cycling or redox state with the adenovirus-
shRNA knock-down of malic enzyme. Thus, the role of malic 
enzyme and pyruvate cycling in metabolism-coupled insulin 
secretion remains an open question. Another possible, and 
likely explanation, is that there is a redundancy of these mito-
chondrial-cytosolic substrate cycle, and that malate-pyruvate 
cycle and the citrate-malate-pyrvate cycle work concurrently. 
The loss of any one cycle with low degree of metabolic control 
[27], as was done in the shRNA knock-down studies in islets 
[28], would lead to the conclusion that that particular cycle 
was unimportant for regulating glucose stimulated insulin se-
cretion. A redundancy of cycles would share responsibility for 
the transfer of reducing equivalents to the cytosol, and could 
result in no single cycle having a high degree of metabolic 
control [27,28].
  Regardless of the pathway, or pathways, responsible for pro-
viding cytosolic NADPH, compelling data supports its role as 
a mitochondrial second messenger. Two key steps in metabo-
lism-coupled insulin secretion have been identified as sites 
where NADPH may exert regulatory control over rates of in-
sulin release. The first site influences the initial events whereby 
NADPH levels can modulate intracellular concentrations of 
Ca
2+. The second site of action is near the final events of secre-
tion with NADPH playing a role in insulin granule docking 
and exocytosis. Accumulating evidence suggests that NADPH 
positively modulates Ca
2+ influx through its binding to the 
regulatory subunit of voltage-dependent K
+ (Kv) channels 
[29]. Kv channels act to repolarize the β-cell following the de-
polarization induced by closure of the KATP channels, and 
hence are negative regulators of insulin release. Additional 
levels of localized regulatory control over NADPH binding to 
Kv channels, and hence Ca
2+ levels, are provided by the oxido-
reductase activity of Kv subunits, and by other membrane as-
sociated oxidoreductases. Closer to the final events of insulin 
release, the reduction of glutathione by NADPH is hypothe-
sized to be instrumental in potentiating insulin exocytosis 
[23]. Glutathione is thought to play a role in the post-transla-
tional modification of the t-SNARE proteins integral to insulin 
granule maturation and membrane docking. Hence, at least 
two mechanisms exist whereby NADPH, generated by pyru-
vate cycling, acts to regulate rates of insulin secretion in pro-
portion to rates of mitochondrial metabolism.
OTHER NOVEL MITOCHONDRIAL 
SUBSTRATE CYCLES
In addition to mitochondrial-cytosolic malate cycling, two 
mammalian mitochondrial isoforms exist; malic enzyme 2 
(ME2) with a preference for NAD
+, and an NADP
+-dependent 
malic enzyme 3 (ME3). In human and rat islets, and in INS-1 
832/13 cells, ME2 is expressed at levels comparable to the ex-
pression of the cytosolic isoform, ME1. The enzymatic proper-
ties of ME2 support the hypothesis that ME2 can provide an 
alternative source of pyruvate from fumarate precursors such 
as glutamine when glycolytic flux is low [30]. Intriguingly, the 
work of Teller et al. [31] suggests that hetero-enzyme interac-
tions of ME2 and the PDH complex serve to channel ME2-
generated pyruvate to PDH in preference to the pool of free 
pyruvate. Using siRNA knock-down and isotope tracer tech-
nology, we found that reduction in ME2 blunted both gluta-
mate flux into the Kreb’s cycle and amino acid stimulated in-
sulin secretion [19]. Thus, mitochondrial malic enzyme 2 me-
diates a mitochondrial-pyruvate cycle that utilizes the anaple-
rotic entry of glutamate to provide a source of pyruvate for 
mitochondrial activation.
  Recently, a novel role for mitochondrial GTP production as 
a direct link to Kreb’s cycle flux and glucose-stimulated insulin 
secretion has become recognized [32]. Mitochondrial GTP is 
an isolated pool and is generated in direct proportion to Kreb’s 
cycle flux rate by the action of the GTP-dependent isoform of 
succinyl-CoA synthetase. Although isolated, the GTP that is 
generated supports the cycling of mitochondrial oxaloacetate 
to cytosolic phospho-enol-pyruvate (PEP) by the action of mi-
real-time PCR462
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tochondrial PEPCK (PEPCK-M) [33]. The existence of this 
cycle in β-cells (Fig. 1) had long been discounted, and the role 
of PEPCK-M in metabolism-coupled insulin secretion was 
unappreciated before these recent studies. In fact, mitochon-
drial PEPCK contributes a substantial fraction of cytosolic 
PEP (30% to 40%) in INS-1 cells and in rat islets, and the loss 
of this contribution almost completely blocks GSIS. Mito-
chondrial PEPCK, as well as GTP-SCS is expressed at substan-
tial levels in human, mouse, and rat islets, supporting its im-
portance across species, including humans. Preliminary data 
from our laboratory found that expression of SCS-GTP and is 
decreased in the DN-HNF-1α β-cell line, and warrant future 
studies on the possibility that dysregulation of the PEP cycling 
mediated by mitochondrial PEPCK may also contribute to 
impaired GSIS in MODY-3, and potentially type 2 diabetes 
metabolism.
RELEVANCE TO HUMAN ISLET BIOLOLGY
Mechanistic insights learned from our studies in β-cell lines, 
and mouse and rat islets are invaluable to better understand-
ing the role of anaplerosis and substrate cycling in porcine and 
human islets. However, the multiplicity of isoforms involved 
in redundant and complementary substrate cycles, the vari-
ance in their degree of metabolic control, and the potential for 
species-dependency of expression and activity in islet β-cells 
make it critical to understand their functions in human islets. 
Using real-time PCR, we found that the human islets ex-
pressed all the critical pathways of anaplerosis, malate-pyru-
vate cycling and PEP cycling [34]. Pyruvate carboxylase, both 
the cytosolic and mitochondrial isoforms of malic enzyme, 
and both the ATP and GTP isoforms of succinyl-CoA synthe-
tase, and mitochondrial PEPCK were expressed at similar lev-
els. We also evaluated human islet β-cell function and found 
that with glucose-stimulation of insulin secretion, rates of ATP 
production, and the generation of the anaplerotic products, ci-
trate and malate, were similar to those that we previously 
found in INS-1 832/13 cells and in rodent islets. 
  A recent report by MacDonald et al. [35] indicates a lesser 
role for pyruvate carboxylase and anaplerosis in human regu-
lating stimulated insulin secretion. Multiple lines of evidence, 
including enzyme activities, mRNA expression, and substrate 
flux measurements, indicate that PC activity is reduced by as 
much as 80% to 90%. Despite the dramatic reduction in PC 
enzyme activity though, they found that the production of 
malate by human islets was only reduced by one-half in com-
parison to rat islets. Since malate production is dependent 
upon PC flux, the ample production of malate suggests that 
PC flux is still sufficient to support those cycles tied to insulin 
secretion. As is the case for rat islets, the enzyme distribution 
indicates a redundancy of pyruvate cycles in human islets. 
While, ATP Citrate Lyase, an enzyme integral to the citrate-
malate-pyruvate cycle was found to be decreased, cytosolic 
malic enzyme activity and expression in human islets were 
similar to that in rat islets. In summary, the cumulative data 
suggests that the differences between rodent and human β-cells 
for the regulatory role of mitochondrial activation, anaplero-
sis, and substrate cycling may be one of degree, but not of 
function, for stimulated insulin secretion.
ARE OUR MECHANISTIC MODELS 
RELEVANT TO GSIS IN VIVO? 
Finally, let us consider the possibility that our models are arti-
facts of our experimental conditions. The majority of our mech-
anistic models of metabolism-coupled insulin secretion are 
derived from results obtained under simplistic experimental 
conditions, and may not be representative of the complex in 
vivo conditions experienced by the islet β-cell within the pan-
creas. Consider the consensus theory of glucose-stimulated 
insulin secretion [1]. Central to this mechanism is that an in-
crease in glucose metabolism and mitochondrial oxidative 
phosphorylation leads to an increase in cytosolic ATP concen-
trations to initiate closure of the KATP channel. This theory 
would predict that with the increase in oxidative phosphoryla-
tion, a proportional increase in oxygen consumption rates 
should occur. And in fact, this does hold when the glucose is 
increased from “basal” to stimulatory concentrations in mini-
mal media. However, when the same studies are done in a 
more physiologically-complex media, the correlation between 
the change in oxygen consumption rate (OCR) and stimulated 
insulin secretion breaks down. In mouse βHC9 cells, Papas 
and Jarema [36] observed the change in the insulin secretion 
was proportional to the change in OCR, when the cells were 
stimulated with 15 mM glucose in the minimal media of phos-
phate buffered saline. However, despite a 2-fold increase in in-
sulin secretion in response to 15 mM glucose, there was no 
observed change in OCR, and presumably oxidative phos-
phorylation, in more nutrient-complex Dubelco’s Minimal 
Eagle Media (DMEM) buffer. We observed similar results for 463
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the rat insulinoma INS-1 832/13 cells, and for isolated rat is-
lets. 
  Studies to identify which of the several possible scenarios 
could be responsible for this anomaly are under active investi-
gation [37]. Using 
31P-NMR to measure ATP synthesis in real-
time, we were able to show that increasing glucose from 2.5 
mM to 15 mM led to identical increases in ATP synthesis rates 
in both minimal and complex media, with the correlation of 
insulin secretion rates vs. ATP synthesis rates falling on two 
distinct and approximately parallel lines for KRB and DMEM. 
Another possibility is that the complexity of the media per-
turbs the role of anaplerosis and the export of putative mito-
chondria second messenger. Using [U-
13C]glucose as a tracer 
to calculate the relative pathways and substrates into the Kreb’s 
cycle. In both DMEM and KRB, the transition from basal con-
centrations to stimulatory concentrations led to similar in-
creases in the entry of glucose into the Kreb’s cycle following 
its conversion to pyruvate and acetyl-CoA for citrate synthesis. 
Increasing glucose led to similar changes in anaplerotic flux, 
such that insulin secretion rates strongly correlated with anaple-
rosis via pyruvate carboxylase flux. In fact, the correlation in 
KRB was congruent that the correlation in DMEM. The strong 
correlation between anaplerosis and rates of insulin secretion 
in DMEM and KRB, and especially their congruency, lends 
further support to the hypothesis that the export of mitochon-
drial second messengers couples mitochondrial metabolism 
to insulin secretion. As discussed above, NADPH is a leading 
candidate for such a role; however the studies of Kibbey et al. 
and Stark et al. [32,33] hint at the possibility that other un-
identified cytosolic signaling pathways coupled to metabolism 
augment insulin secretion in vivo. 
  In conclusion, mitochondria of pancreatic islet β-cells regu-
late insulin secretion by means of an integrated signal provid-
ed by ATP production, anaplerosis, mitochondrial-cytosolic 
and mitochondrial-mitochondrial substrate cycling, the regu-
lation of cellular redox state, and the production of other sec-
ondary signaling intermediates. Those signaling mechanisms 
that are linked to the rates of anaplerosis, the Kreb’s cycle, and 
substrate cycling enhance regulated rates of insulin secretion 
above that provided by ATP production alone.
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